Skip to main content
Log in

Successful treatment of a patient with SAPHO syndrome with certolizumab pegol

  • Letter to the Editor - Cases with a Message
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Chamot AM, Benhamou CL, Kahn MF et al (1987) Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic 54:187–196

    CAS  PubMed  Google Scholar 

  2. Benhamou CL, Chamot AM, Kahn MF (1988) Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 6:109–112

    CAS  PubMed  Google Scholar 

  3. Sieper J, Rudwaleit M, Baraliakos X et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–ii44

    Article  PubMed  Google Scholar 

  4. Nguyen MT, Borchers A, Selmi C et al (2012) The SAPHO syndrome. Semin Arthritis Rheum 42:254–265

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Seiji Minota has received an unlimited research grant from Astellas Pharma Inc.

Conflict of interest

Yasuyuki Kamata has no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuyuki Kamata.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kamata, Y., Minota, S. Successful treatment of a patient with SAPHO syndrome with certolizumab pegol. Rheumatol Int 35, 1607–1608 (2015). https://doi.org/10.1007/s00296-015-3263-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-015-3263-8

Keywords

Navigation